F&V Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-63,881
| Closed | -$4.7M | – | 62 |
|
|
2021
Q1 | $4.7M | Sell |
63,881
-1,439
| -2% | -$106K | 1.76% | 28 |
|
|
2020
Q4 | $5.1M | Buy |
65,320
+1,122
| +2% | +$85.8K | 2.2% | 26 |
|
|
2020
Q3 | $5.08M | Sell |
64,198
-27
| -0% | -$2.12K | 2.47% | 19 |
|
|
2020
Q2 | $4.74M | Buy |
64,225
+6,587
| +11% | +$496K | 2.4% | 21 |
|
|
2020
Q1 | $4.23M | Buy |
57,638
+142
| +0.2% | +$11.2K | 2.69% | 18 |
|
|
2019
Q4 | $4.99M | Sell |
57,496
-1,441
| -2% | -$118K | 2.71% | 17 |
|
|
2019
Q3 | $4.73M | Sell |
58,937
-23,622
| -29% | -$1.89M | 2.93% | 18 |
|
|
2019
Q2 | $6.61M | Sell |
82,559
-2,563
| -3% | -$196K | 3.94% | 4 |
|
|
2019
Q1 | $6.75M | Sell |
85,122
-5,633
| -6% | -$421K | 3.86% | 5 |
|
|
2018
Q4 | $6.62M | Buy |
90,755
+2,479
| +3% | +$175K | 4% | 4 |
|
|
2018
Q3 | $5.97M | Sell |
88,276
-1,137
| -1% | -$72.4K | 3.21% | 17 |
|
|
2018
Q2 | $5.18M | Sell |
89,413
-5,102
| -5% | -$288K | 2.97% | 18 |
|
|
2018
Q1 | $4.91M | Sell |
94,515
-1,019
| -1% | -$55K | 2.68% | 17 |
|
|
2017
Q4 | $5.13M | Buy |
95,534
+2,138
| +2% | +$119K | 2.66% | 17 |
|
|
2017
Q3 | $5.71M | Sell |
93,396
-1,058
| -1% | -$64.1K | 3.34% | 13 |
|
|
2017
Q2 | $5.78M | Sell |
94,454
-364
| -0.4% | -$22.2K | 3.28% | 11 |
|
|
2017
Q1 | $5.75M | Buy |
94,818
+2,542
| +3% | +$154K | 3.34% | 11 |
|
|
2016
Q4 | $5.18M | Buy |
92,276
+5,716
| +7% | +$335K | 3.26% | 11 |
|
|
2016
Q3 | $5.16M | Buy |
86,560
+1,064
| +1% | +$62.2K | 3.57% | 11 |
|
|
2016
Q2 | $4.7M | Sell |
85,496
-1,216
| -1% | -$64.7K | 3.5% | 14 |
|
|
2016
Q1 | $4.38M | Sell |
86,712
-2,137
| -2% | -$105K | 3.45% | 15 |
|
|
2015
Q4 | $4.48M | Buy |
88,849
+2,473
| +3% | +$125K | 3.27% | 15 |
|
|
2015
Q3 | $4.07M | Buy |
86,376
+786
| +0.9% | +$41.8K | 2.89% | 17 |
|
|
2015
Q2 | $4.65M | Buy |
85,590
+2,061
| +2% | +$116K | 3.16% | 13 |
|
|
2015
Q1 | $4.58M | Buy |
83,529
+2,770
| +3% | +$157K | 3.12% | 11 |
|
|
2014
Q4 | $4.38M | Buy |
80,759
+5,837
| +8% | +$325K | 2.98% | 12 |
|
|
2014
Q3 | $4.24M | Sell |
74,922
-2,378
| -3% | -$134K | 3.14% | 6 |
|
|
2014
Q2 | $4.27M | Buy |
77,300
+911
| +1% | +$49.7K | 3.16% | 9 |
|
|
2014
Q1 | $4.14M | Sell |
76,389
-11,502
| -13% | -$596K | 3.27% | 10 |
|
|
2013
Q4 | $4.2M | Sell |
87,891
-3,013
| -3% | -$138K | 3.34% | 10 |
|
|
2013
Q3 | $4.13M | Buy |
90,904
+2,924
| +3% | +$134K | 3.5% | 9 |
|
|
2013
Q2 | $3.9M | Buy |
+87,980
| New | +$3.93M | 3.73% | 5 |
|
Other funds holding MRK
F&V Capital Management's MRK Position: Q2 2021 in Review
F&V Capital Management sold out of Merck (MRK) in Q2 2021, closing a stake of 63,881 shares — an estimated $4.7M sold.
F&V Capital Management first reported a position in MRK in Q2 2013 and held it in 32 quarters. The position peaked at $6.75M in Q1 2019. 2,673 funds tracked by Wall St. Rank hold MRK as of Q2 2021.
- F&V Capital Management reported no remaining Merck position as of Q2 2021 after selling out during the quarter.
- F&V Capital Management sold 63,881 Merck shares in Q2 2021, an estimated $4.7M.
- F&V Capital Management first reported a position in Merck in Q2 2013 and held it in 32 quarters.
- F&V Capital Management's Merck position peaked at $6.75M in Q1 2019.
- 2,673 funds tracked by Wall St. Rank held Merck as of Q2 2021.
Based on F&V Capital Management's 13F filing for Q2 2021, filed 9 Jul 2021.